The President announced under Rule 64(1) that the following positions had been received from the Council, together with the reasons which had led to their adoption, and the Commission's position on:
- Position of the Council at first reading with a view to the adoption of a regulation of the European Parliament and of the Council on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (10728/4/2016 - C8-0104/2017 – 2012/0266(COD) - 06592/1/2017 - COM(2017)0129)
referred back to committee responsible: ENVI
- Position of the Council at first reading with a view to the adoption of a regulation of the European Parliament and of the Council on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (10729/4/2016 - C8-0105/2017 – 2012/0267(COD) - 06593/1/2017 - COM(2017)0127)
referred back to committee responsible: ENVI
The three-month period available to Parliament to adopt its positions would therefore begin the following day, 17 March 2017.